Once-monthly efimosfermin alfa prescribed for metabolic dysfunction–associated steatohepatitis with F2 and F3 fibrosis ...

Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment ...

Use of the investigational drug efruxifermin did not significantly reduce fibrosis in patients with compensated cirrhosis ...

Target RWE, a leader in modern clinical evidence generation for complex diseases, today announced its presentations and strategic contributions at the EASL Congress 2025 in Amsterdam, Netherlands.

AMSTERDAM — A once daily, 50 mg dose of efruxifermin reduced fibrosis at 96 weeks in patients with compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis (MASH) compared with ...

Sam and Joe discuss the MASH unit that is the Cleveland Cavaliers and if there is any hope of the East's number one seed ...

Related: Costco's 'Sparkling' and 'Tangy' Summery Treat Has Fan's Racing to Stores: 'Need to Find These ASAP' ...

The publication reports results from the 96-week SYMMETRY study evaluating the efficacy and safety of Akero's lead FGF21 ...

“It is an absolute phenom for us to be able to present to you now our teenage aspirations in this song”: Joe Satriani and ...

These include a series of bottled-in-bond vintage releases, and the details of the latest one were just announced.

The distilleries that populate the state have offerings for those who love history, nature, and of course the liquor.

Doom: The Dark Ages is a slay. Its intense battles and awe-inspiring scale outweighs its inconsistent parts by a high ...